Childhood-onset multiple sclerosis with progressive dementia and pathological cortical demyelination

Archives of Neurology

Volumn 68, Issue 4, 2011, Pages 525-528

  Bunyan, Reem F ^a   Popescu, Bogdan F Gh ^a   Carter, Jonathan L ^b   Caselli, Richard J ^b   Parisi, Joseph E ^a   Lucchinetti, Claudia F ^a  

^a MAYO CLINIC   (United States)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLATIRAMER; IMMUNOGLOBULIN; NATALIZUMAB; STEROID;

ADULT; ARTICLE; BRAIN BIOPSY; BRAIN CORTEX DEMYELINATION; CASE REPORT; CELL ACTIVATION; CEREBROSPINAL FLUID; DEMENTIA; DEMYELINATION; DISEASE COURSE; DISEASE DURATION; HUMAN; HUMAN TISSUE; MALE; MICROGLIA; MULTIPLE SCLEROSIS; NEUROLOGIC EXAMINATION; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; ONSET AGE; PRIORITY JOURNAL; PROGRESSIVE DEMENTIA; TREATMENT FAILURE; UNITED STATES;

ADULT; AGE FACTORS; CEREBRAL CORTEX; DEMENTIA; DEMYELINATING DISEASES; DISEASE PROGRESSION; HUMANS; MALE; MULTIPLE SCLEROSIS; MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE;

EID: 79953898724     PISSN: 00039942     EISSN: 15383687     Source Type: Journal    
DOI: 10.1001/archneurol.2011.50     Document Type: Article

References (11)

1. Calabrese M, Agosta F, Rinaldi F, et al. Cortical lesions and atrophy associated with cognitive impairment in relapsing-remitting multiple sclerosis. Arch Neurol. 2009;66(9):1144-1150.
2. Staff NP, Lucchinetti CF, Keegan BM. Multiple sclerosis with predominant, severe cognitive impairment. Arch Neurol. 2009;66(9):1139-1143.
3. Gusev E, Boiko A, Bikova O, et al. The natural history of early onset multiple sclerosis: comparison of data from Moscow and Vancouver. Clin Neurol Neurosurg. 2002;104(3):203-207. (Pubitemid 34792725)
4. Mikaeloff Y, Caridade G, Assi S, Suissa S, Tardieu M. Prognostic factors for early severity in a childhood multiple sclerosis cohort. Pediatrics. 2006;118(3):1133-1139. (Pubitemid 46090056)
5. Lucchinetti C, Brück W, Parisi J, Scheithauer B, Rodriguez M, Lassmann H. Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination. Ann Neurol. 2000;47(6):707-717. (Pubitemid 30390191)
6. Bø L, Vedeler CA, Nyland HI, Trapp BD, Mørk SJ. Subpial demyelination in the cerebral cortex of multiple sclerosis patients. J Neuropathol Exp Neurol. 2003;62(7):723-732. (Pubitemid 36870458)
7. Peterson JW, Bö L, Mörk S, Chang A, Trapp BD. Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions. Ann Neurol. 2001;50(3):389-400. (Pubitemid 32848742)
8. Kelley BJ, Boeve BF, Josephs KA. Young-onset dementia: demographic and etiologic characteristics of 235 patients. Arch Neurol. 2008;65(11):1502-1508.
9. Amato MP, Goretti B, Ghezzi A, et al; Multiple Sclerosis Study Group of the Italian Neurological Society. Cognitive and psychosocial features in childhood and juvenile MS: two-year follow-up. Neurology. 2010;75(13):1134-1140.
10. MacAllister WS, Belman AL, Milazzo M, et al. Cognitive functioning in children and adolescents with multiple sclerosis. Neurology. 2005;64(8):1422-1425. (Pubitemid 40570512)
11. Kutzelnigg A, Lassmann H. Cortical demyelination in multiple sclerosis: a substrate for cognitive deficits? J Neurol Sci. 2006;245(1-2):123-126. (Pubitemid 43775930)